Skip to content

Screening for Glaucoma in Namil Area, South Korea

Epidemiologic Study for the Prevalence of Glaucoma in Namil Area, Geumsan City, South Korea

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00727168
Enrollment
1532
Registered
2008-08-01
Start date
2007-11-30
Completion date
2008-02-29
Last updated
2008-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma, Intraocular Pressure, Optic Nerve Head, Visual Field

Keywords

prevalence study, glaucoma

Brief summary

The purpose of this study is to study the prevalence of glaucoma in Korea, the investigators selected Namil area in Geumsan city, located in central Korea. The residents aged over 40 in this area are to be recruited to full ophthalmologic examination to detect and classify the glaucoma.

Detailed description

Screening includes following examinations; Questionaire and Consent form, Visual acuity test, Auto-refraction, IOL Master measurement, Pachymetry, FDT Perimetry, Fundus Photography, Slit lamp examination, Goldmann applanation Tonometry, Gonioscopy, and Binocular optic disc evaluation. For the cases showing any abnormality in FDT perimetry, optic disc morphology, or intraocular pressure, Humphrey automated visual field test is to be performed as an extended examination. Finally, optic nerve head evaluation by OCT or GDx analyzer is to be used as a confirmation test, as well as additional Humphrey visual field test.

Interventions

None listed

Sponsors

Korean Glaucoma Society
Lead SponsorNETWORK

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* All residents aged over 40 in Namil area

Exclusion criteria

* Individuals registered but not actually living in this area

Design outcomes

Primary

MeasureTime frame
Prevalence of glaucoma in Namil areacross-sectional

Secondary

MeasureTime frame
Clinical factors associated with the glaucomacross-sectional

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 25, 2026